Close
Digital Health & Ai Innovation summit 2026
APE 2026

IBM Unveils Next Generation Of Enterprise Health Analytics

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Supplier Quality Management in Complex Pharma...

Overseeing the intricate web of global providers for raw materials and contract services is essential for ensuring product safety and maintaining a resilient pharmaceutical supply chain in a volatile market.

GMP Audits Driving Continuous Quality Excellence

Far from being mere regulatory hurdles, internal and external Good Manufacturing Practice assessments serve as vital catalysts for institutional growth and the pursuit of operational perfection in pharmaceutical production.

Digital Quality Systems Transforming Compliance Models

The transition from manual quality assurance to integrated digital platforms is redefining how pharmaceutical and medical device companies maintain regulatory readiness and operational agility.
IBM has announced on Tuesday, February 26th  at HIMSS08 a portfolio of health analytics solutions for health systems.

IBM's Enterprise Health Analytics harness the power of information generated by today's healthcare industry by converting it into new, data-driven intelligence.

IBM has announced on Tuesday, February 26th  at HIMSS08 a portfolio of health analytics solutions for health systems.

IBM's Enterprise Health Analytics harness the power of information generated by today's healthcare industry by converting it into new, data-driven intelligence.

IBM's Enterprise Health Analytics are a complete suite of services, infrastructure, and tools that can be tailored to the needs of any client — from entry level, off-the-shelf analytics capabilities to custom-built data warehouses for academic and research settings. The solutions fill a significant void in data integration and intelligent analyses that currently poses a major barrier to transformation in the Healthcare Industry.

Dan pelino , General Manager, IBM Global Healthcare & Life Sciences Industry. said IBM has witnessed an explosion of data and complexity in the healthcare industry over the past two decades. Hospitals moved to adopt Electronic Medical Records. Technology vendors delivered proprietary applications that captured and integrated discrete data to improve clinical processes. And the demand for clinical and departmental systems accelerated.

IBM's Enterprise Health Analytics solutions will help health systems report, trend and analyse key organisational, financial and clinical metrics; access information to manage and report the progression and impact of chronic diseases; predict high-risk populations and begin early interventions for wellness management; view and analyse aggregated, specific data sets by specific populations for cohort management, disease registries, clinical guidelines, and patient safety; and prepare for evidence-based medicine, leading to the practice of personalised medicine.

IBM's Enterprise Health Analytics transforms information through a simplified process that integrates and aggregates disparate data from multiple sources for practical use. Data is transformed through a Business Intelligence Reference Architecture that transforms disparate data, making it available in a timely manner for analysis that can solve specific clinical, business and research problems.

Latest stories

Related stories

Supplier Quality Management in Complex Pharma Networks

Overseeing the intricate web of global providers for raw materials and contract services is essential for ensuring product safety and maintaining a resilient pharmaceutical supply chain in a volatile market.

GMP Audits Driving Continuous Quality Excellence

Far from being mere regulatory hurdles, internal and external Good Manufacturing Practice assessments serve as vital catalysts for institutional growth and the pursuit of operational perfection in pharmaceutical production.

Digital Quality Systems Transforming Compliance Models

The transition from manual quality assurance to integrated digital platforms is redefining how pharmaceutical and medical device companies maintain regulatory readiness and operational agility.

Advancing Data Integrity Across Biotech Manufacturing

Ensuring the accuracy and reliability of information is the lifeblood of biotechnology production, where even minor discrepancies in digital or physical records can compromise product safety and regulatory standing.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »